(Q46721516)

24 December 2017

title

Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers (English)

1 reference

24 December 2017

1 reference

1 reference

5

M Petri

1 reference

24 December 2017

E Akhter

1

1 reference

24 December 2017

R W Burlingame

series ordinal

2

1 reference

24 December 2017

A L Seaman

series ordinal

3

1 reference

24 December 2017

L Magder

series ordinal

4

1 reference

24 December 2017

publication date

3 August 2011

1 reference

24 December 2017

published in

Lupus

1 reference

24 December 2017

volume

20

1 reference

24 December 2017

issue

12

1 reference

24 December 2017

page(s)

1267-1274

1 reference

24 December 2017

The 1982 revised criteria for the classification of systemic lupus erythematosus

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

SLE patients with renal damage incur higher health care costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Clinical and biological aspects of anti-P-ribosomal protein autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Complement component c1q and anti-c1q antibodies in theory and in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

21 January 2018

Anti-C1q autoantibodies

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Autoantibodies against C1q: view on clinical relevance and pathogenic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

The adhesion molecules of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Serological markers of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Antinucleosome antibodies as a marker of active proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Combined oral contraceptives in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

Relationship between lupus nephritis activity and the serum level of soluble VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203311411597

21 January 2018

Identifiers

DOI

10.1177/0961203311411597

1 reference

24 December 2017

1 reference

24 December 2017